Although some healthcare stocks, including Bristol Myers Squibb ( BMY ), already experienced an inflection point in trading momentum, you can't change my mind. I still stand by my thought that the market overlooks these defensiveDear Reader,I am a Senior Derivatives Expert with over 10 years of experience in the field of Asset Management, specializing in equity analysis and research, macroeconomics, and risk-managed portfolio construction. My professional background covers both institutional and private cli ...